New drug application: Difference between revisions

From DISI
Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 1: Line 1:
A new drug application (NDA) is an application submitted by the manufacturer of a drug to the FDA - after [[clinical trials]] have been completed - for a license to market the drug for a specified indication.
A new drug application (NDA) is an application submitted by the manufacturer of a drug to the FDA - after [[clinical trials]] have been completed - for a license to market the drug for a specified indication.
[[Category:Jargon]]

Revision as of 20:33, 6 August 2009

A new drug application (NDA) is an application submitted by the manufacturer of a drug to the FDA - after clinical trials have been completed - for a license to market the drug for a specified indication.